Roberta S. Azevedo, Nicholas Short, Alex Bataller, Naval Daver, Tapan Kadia, Courtney DiNardo, Alexandre Bazinet, Ghayas Issa, Elias Jabbour, Gautam Borthakur, Jayastu Senapati, Wei-Ying Jen, Kelly Chien, Steven Kornblau, Dono Tippett, Musa Yilmaz, Guillermo Montalban-Bravo, Hagop Kantarjian, Guillermo Garcia-Manero, Farhad Ravandi. "Phase I/II study of decitabine/cedazuridine (ASXT727), venetoclax, and gilteritinib for patients with FLT3-mutated Acute Myeloid Leukemia or high-risk myelodysplastic syndrome." Blood, 2025. doi:10.1182/blood-2025-997